Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Research Article Volume 7 Issue 1

Epidemiology of Gastrointestinal Cancer Result from Hospital Based Cancer Registry Data

Seema Devi1*, Rajesh Kumar Singh2, Shradha Raj3, Abhishek Kumar4 and Aman Prakash5

1Additional Professor, Department of Radiation Oncology, IGIMS, Patna, India
2Professor, Department of Radiation Oncology, IGIMS, Patna, India
3Assistant Professor, Department of Radiation Oncology, IGIMS, Patna, India
4PG 3rd Year, Department of Radiation Oncology, IGIMS, Patna, India
5Statistian, State Cancer Institute, IGIMS, Patna, India

*Corresponding Author: Seema Devi, Additional Professor, Department of Radiation Oncology, IGIMS, Patna, India.

Received: February 13, 2023; Published: February 28, 2023


Background: 19.3 million new cases and almost 10 million cancer deaths are estimated, Cancer of gastrointestinal tract represent about one-fifth (30%) of cancer incidence and about one-third (40%) of all cancer related deaths. Approximately 1 million new cases of carcinoma stomach and 769000 deaths. Ranking 5th for incidence and fourth in position for cancer-related death. According to the Indian Cancer Registry Programme in 2020, 1400000 new cases were diagnosed. This article describes the Hospital Based Cancer Registry incidence of various types Cancer in the region under investigation of Gallbladder, Liver , Stomach, Colorectum, pancreas and esophagus which includes Gallbladder cancer, Liver cancer, stomach cancer, Colorectal cancer, Pancreas cancer and esophagus cancer.

Material and Method: Retrospective observational study was conducted in the Department of Radiation Oncology at State Cancer Institute, Patna, (Bihar). We analyzed the cancer records from 2014 to 2022, all the histopathologic ally confirmed cases of GIT cancer including gallbladder cancer and biliary tract disease, esophagus cancer, stomach cancer, liver cancer, pancreas cancer, colorectal cancer were included. We analyzed the data decoding according to disease, Common age group, Male: Female ratio of upper GIT tumor.

Result: Total Gastro Intestinal Tumor cases in our study were 27.4% of all registered cases. Most common cancer of upper GIT in a study was carcinoma gall bladder in which 4204 cases were registered. Most of the cases registered were from Patna. Most common age group was 50-60 years of age. which contributed 1748 cases (41.5%) cases. Most of the cases registered were from Patna district as well as 2nd most cases were registered in Vaishali District, Muzaffarpur was 3rd according to number of cases.

Keywords: HBCR Cancer Gallbladder; Cancer Liver; Cancer Stomach; Cancer Pancreas; Cancer Colorectal; Cancer Esophagus


  1. Globocan (2020).
  2. Islami F., et al. “Proportion and number of cancer cases and death attributed to potentially modifiable risk factors in the United States”. A Cancer Journal for Clinicians 1 (2018): 31-54.
  3. Nutrition, Physical activity, and Liver Cancer. Continuous Update Project Report: World Cancer Research Fund. American Institute for Cancer Research, (2015).
  4. Diet, Nutrition. Physical activity and Colorectal Cancer Continuous Update: Project Report 2018: world cancer research fund. American Institute for Cancer Research (2018).
  5. Food, Nutrition, Physical activity, and the Prevention of Pancreatic Cancer. Continuous Update Project Report: World Cancer Research Fund. American Institute for Cancer Research (2012).
  6. Diet, Nutrition, Physical activity, and Stomach Cancer. Continuous Update Project Report: World Cancer Research Fund. American Institute for Cancer Research (2016).
  7. Diet, Nutrition, Physical activity, and Oesophageal Cancer. Continuous Update Project Report: World Cancer Research Fund. American Institute for Cancer Research (2016).
  8. Mathur P., et al. “Cancer Statistics, 2020: Report From National Cancer Registry Programme, India”. JCO Global Oncology 6 (2020): 1063-1075.
  9. Yamaguchi K., et al. “Gall bladder carcinoma in the era of laparoscopic cholecystectomy”. Archives of Surgery 131 (1996): 981-984.
  10. Marinus JPG., et al. “A prospective analysis of 1518 laparoscopy cholecystectomies. The southern surgeons club”. The New England Journal of Medicine 324 (1991): 1073-1078.
  11. Satyanarayana L and Asthana S. “Life time for development of ten major cancers in India and trends over the years 1982 to 2000”. Indian Journal Medical Sciences 62 (2008): 35-44.
  12. Ferlay J., et al. “Global Cancer Observatory: Cancer Tomorrow”. Lyon, France: International Agency for Research on Cancer (2018).
  13. Arnold M., et al. “Global Burden of 5 Major Types of Gastrointestinal Cancer”. Gastroenterology 159 (2020): 335-49.e15.
  14. ICMR-National Centre for Disease Informatics and Research. Report of National Cancer Registry Programme (NCRP 2020). Bangalore, India (2020).
  15. India State- Level Disease Burden Initiative Cancer Collaborators (2018). “The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016”. Lancet Oncology 19 (2018): 1289-306.
  16. Clinicopathological profile of cancers in India: A Report of the Hospital Based Cancer Registries. National Cancer Registry Programme (2021).
  17. Hundal R and Shafter EA. “Gallbladder cancer: Epidemiology and outcome”. Clinical Epidemiology 6 (2011): 99-109.
  18. Ferlay J., et al. “Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012”. International Journal of Cancer 136 (2015): E359-386.
  19. Sachidananda S., et al. “Characteristics of gallbladder cancer in South India”. Indian Journal of Surgical Oncology 3 (2012): 228-230.
  20. Pandey M. “Risk factors for gallbladder cancer: a reappraisal”. European Journal of Cancer Prevention 12 (2003): 15-24.
  21. Pandey M and Shukla VK. “Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer”. European Journal of Cancer Prevention 12 (2003): 269-272.
  22. Tamrakar D., et al. “Risk factors for gallbladder cancer in Nepal a case control study”. Asian Pacific Journal of Cancer Prevention 17 (2016): 3447-3453.
  23. Gupta SK., et al. “Copper, zinc, and Cu/Zn ratio in carcinoma of the gallbladder”. Journal of Surgical Oncology 91 (2005): 204-208.
  24. Nath G., et al. “Association of carcinoma of the gallbladder with typhoid carriage in a typhoid endemic area using nested PCR”. Journal of Infection in Developing Countries 2 (2008): 302-307.
  25. Pandey M., et al. “Bile. bacteria, and gallbladder carcinogenesis”. Journal of Surgical Oncology 58 (1995): 2B2 3.
  26. Dutta U., et al. “Typhoid carriers among patients with gallstones are at increased risk for carcinoma of the gallbladder”. American Journal of Gastroenterology 95 (2000): 784-787.
  27. Kumar S. “Infection as a risk factor for gallbladder cancer”. Journal of Surgical Oncology 93 (2006): 633.
  28. Routh D. “Gallbladder Carcinoma: A Reason to Worry in North and North-Eastern India”. Clinical Surgery 2 (2017): 1661.
  29. Shukla Y and Arora A. “Enhancing effects of mustard oil on prencoplastic hepatic foci development in Wistar rats”. Human and Experimental Toxicology 22 (2003): 51-55.
  30. Shukla VK., et al. “Biliary heavy metal concentrations in carcinoma of the gall bladder. case-control study”. BMJ 317 (1998): 1288-1289.
  31. Wands JR and Blum HE. “Primary hepatocellular carcinoma”. The New England Journal of Medicine 325 (1991): 729-731.
  32. El-serag HB and Mason AC. “Rising incidence of hepatocellular carcinoma in the United States”. The New England Journal of Medicine 340 (1999): 745-750.
  33. Pisani P., et al. “Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden”. International Journal of Cancer 55 (1993): 891-893.
  34. Annual Report 1987. National Cancer Registry Programme. New Delhi, Indian Council of Medical Research, (1990).
  35. Jayant K., et al. “Rural Cancer Registry at Barshi- Report 1988-92”. Barshi, Rural Cancer Registry, (1994).
  36. Pyrsopoulos N and Reddy RK. “Hepatocellular carcinoma in Asia”. In: Sarin SK, Okuda K, eds. Hepatitis B and C. Carrier to Cancer. India, Elsevier Sciences (2002): 363-364.
  37. Singh SV., et al. “Primary carcinoma of liver in Udaipur”. Journal of the Association of Physicians of India 19 (1971): 691-695.
  38. Agarwal AK., et al. “Clinical diagnosis of hepatoma”. Journal of the Association of Physicians of India 14 (1966): 465-468.
  39. Dinshaw KA., et al. “Hospital cancer registry: annual Report 1994”. Mumbai, Tata Memorial Hospital, (1997).
  40. Shrestha G., et al. “Cancer Incidence in Nepal: A Three- Year Trend Analysis 2013-2015”. Asian Pacific Journal of Cancer Prevention Care 5 (2020): 145-150.
  41. Bray F., et al. “Cancer Incidence in Five Continents”. Vol. XI (electronic version). Lyon; International Agency for Research on Cancer.
  42. “GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017 a systematic analysis for the Global Burden of Disease study 2017”. Lancet Gastroenterology and Hepatology 5 (2020): 42-54.
  43. Kamangar F., et al. “The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017 a systematic analysis for the Global Burden of Disease Study 2017”. Lancet Gastroenterology and Hepatology 5 (2020): 582-597.
  44. Fedirko V., et al. “Alcohol drinking and colorectal cancer risk, an overall und dose-response meta-analysis al published studies”. Annals of Oncology9 (2011): 1958-1972.
  45. Bouvard V., et al. “Carcinogenicity of consumption of red and processed meat”. Lancet Oncology (2015).
  46. Norat T., et al. “Meat consumption and colorectal cancer risk: dose response meta-analysis of epidemiological studies”. International Journal of Cancer 98/2 (2002): 241-256.
  47. Renehan AG., et al. “Body-mass index and incidence of cancer: a systematic review and meta analysis of prospective observational studies”. Lancet9612 (2008): 569-578.
  48. Czito BW. “Colon cancer”. In: Tepper GA, editor, Clinical Radiation Oncology. Edinburgh, UK: Churchill Livingstone: (2007): 1101-11.
  49. Heinrich S., et al. “Adjuvant gemeitabine versus NEO adjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabin in resectable pancreatic cancer. A randomized multicenter phase III study (NEOPAC study)”. BMC Cancer 11 (2011): 346.
  50. Ezzati M., et al. “Role of smoking in global and regional cancer epidemiology: Current patterns and data needs”. International Journal of Cancer 116 (2005): 963-971.
  51. Weiss W and Benarde MA. “The temporal relation between cigarette smoking and pancreatic cancer”. American Journal of Public Health 73 (1983): 1403-1404.
  52. Yadav D and Lowenfels AB. “The epidemiology of pancreatitis and pancreatic cancer”. Gastroenterology 144 (2013): 1252-1261.
  53. Chari ST., et al. “Risk of pancreatic carcinoma in tropical calcifying pancreatitis. An epidemiologic study”. Pancreas 9 (1994): 62-66.
  54. Sant M., et al. “EUROCARE-3: Survival of cancer patents diagnosed 1990-94-results and commentary”. Annals of Oncology 14 (2003): 61-118.
  55. Coleman MP., et al. “Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (The International cancer benchmarking partnership): An analysis of population-based cancer registry data”. Lancet 377 (2011): 127-138.
  56. Hospital cancer registry. In: Badwe RA, Pramesh CS. Ganesh B. Annual Report-2017. Mumbai: Tata Memorial Hospital; (2019).
  57. Consolidated Report of Hospital Based Cancer Registries: 2012-2014, NGDIR, ICMR. (2016a).
  58. Bray F., et al. “Global cancer transitions according to the Human Development Index (2008-2030): A population-based study”. Lancet Oncology 13 (2012): 790-801.
  59. Ferlay J., et al. “Global Cancer Observatory: Cancer Tomorrow”. Lyon, France: International Agency for research on Cancer (2018).
  60. Cherian JV., et al. “Carcinoma of the esophagus in Tamil Nadu (South India): 16-year trends from a tertiary center”. Journal of Gastrointestinal and Liver Diseases 16 (2007): 245-249.
  61. Rasool S., et al. “Esophnseal cancer assochared actors with spectal reference to the Kashmir Valley”. Tumori 98 (2012): 191-203.
  62. Khuroo MS., et al. “High incidence of oesophageal and gastre cancer in Kashmir in a population with special personal and dietary habits”. Gut 33 (1992): 11-15.
  63. Li JY. “Epidemiology of esophageal cancer in China”. National Cancer Institute Monograph Series 62 (1982): 113-120.
  64. McCollum AD., et al. “The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer”. American Journal of Clinical Oncology 29 (2006): 40-44.
  65. F Kamangar., et al. “Patterns of cancer incidence, mortality, and prevalence across five continents. Defining priorities to reduce cancer disparities in different geographic regions of the world". Journal of Clinical Oncology14. (2006): 2137-2150.
  66. Lau CSM., et al. “Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973-2013)”. HPB Surgery (2017): 1-7.
  67. Akhtar-Danesh N., et al. “Treatment Modality and Trends in Survival for Gallbladder Cancer: a Population-Based Study”. Journal of Gastrointestinal Cancer 52 (2021): 256-262.
  68. Three-Year Report of Population Based Cancer Registries 2012-2014. Incidence, Distribution, Trends in Incidence Rates and Projections of Burden of Cancer (Report of 27 PBCRs in India), NCDIR-NCRP, ICMR; (2016).
  69. Dikshit RP., et al. “Epidemiological review of gastric cancer in India”. Indian Journal of Medical and Paediatric Oncology 32 (2011): 3-11.
  70. Mhatre S., et al. “Mustard oil consumption, cooking method, diet and gallbladder cancer risk in high- and low-risk regions of India”. International Journal of Cancer 147 (2020): 1621-1628.
  71. Samarasam I. “Esophageal cancer in India: Current status and future perspectives”. International Journal of Advanced Medical and Health Research 4 (2017): 5-10.
  72. Gupta S., et al. “Relationship between type of smokeless tobacco and risk of cancer: A systematic review”. Indian Journal of Medical Research 148 (2018) 56-76.
  73. Paramita Ghosh., et al. “Clinicopathological characteristics and incidence of gastric cancer in Eastern India: A Retrospective Study”. Journal of Gastrointestinal Cancer 52 (2021): 863-871.


Citation: Seema Devi., et al. “Epidemiology of Gastrointestinal Cancer Result from Hospital Based Cancer Registry Data" Acta Scientific Cancer Biology 7.1 (2023): 22-33.


Copyright: © 2022 Seema Devi., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US